Fortis seeks CCI nod to buy 31.52% more in diagnostics subsidiary Agilus

Fortis is reportedly acquiring the stake from NYLIM Jacob Ballas India Fund III LLC, International Finance Corporation and Resurgence PE Investments for 1,780 crore, valuing Agilus at about 5,700 crore. Agilus is engaged in setting up, managing, maintaining clinical reference laboratories and other laboratories for providing testing and diagnostic services.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/sHDvbjI
via